Correction to: Contrast-enhanced ultrasound (CEUS) of the lung reveals multiple areas of
microthrombi in a COVID-19 patient - PMC Back to Top Skip to main content NIH NLM Logo …

Dear Editor, Peng et al. have outlined several characteristics common to all COVID-19
patients using lung ultrasound and the 12 zone method [1]. Zotzmann et al. in a follow-up …

Objectives Bedside lung ultrasound has been indispensable during the coronavirus disease
2019 (COVID-19) pandemic, allowing us to rapidly assess critically unwell patients. We …

First, a central echogenic spot within a consolidation on conventional US imaging should not
always be considered a synonym for an infarct on computed tomography (CT), by which …

Dear Editor, We congratulate Peng et al.[1] for their timely report on lung ultrasonography in
COVID-19 patients. As reported earlier, pulmonary pathologies in the SARS-CoV-2-induced …

Dear Editor, Initial reports have indicated a higher incidence of venous thromboembolism
(VTE) among patients with coronavirus disease 2019 (COVID-19) compared to other critical …

18F-GP1 is a novel radiotracer that binds to the platelet glycoprotein IIb/IIIa receptor and can
image in vivo venous and arterial thrombi, including deep vein thrombosis and pulmonary …

SARS-CoV-2 binds to the angiotensin-converting enzyme 2 (ACE2) receptors found on
vascular endothelial cells among others. 1 Goshua et al. reported that von Willebrand factor …

The BLUE protocol provides an excellent step‐by‐step approach for diagnosis of acute
dyspnea. Adding FECHO (Focused Echocardiography) to the BLUE protocol completes the …

Background Patients with acute COVID-19 infection can have both cardiac and pulmonary
etiologies for their presenting symptoms. Etiologies include edema, inflammation …